Apple launches health AI usage study with OpenEvidence, seeks up to 200,000 participants
Apple and clinical AI platform OpenEvidence have opened a virtual study for U.S. adults to examine how conversational AI tools affect health decisions and trust.
Apple announced a virtual research study aimed at understanding how users interact with conversational AI for health purposes. The Apple Health AI Usage Study will allow participants to ask health-related questions through a dedicated app and optionally share HealthKit data to assess how personal data integration influences response relevance and comprehension. Up to 200,000 U.S. residents aged 21 or older are eligible to join.
"Insights from this study will help advance the broader scientific conversation and ensure that as technology evolves, we continue building trusted tools that genuinely support people wherever they are on their health journey," said Sumbul Desai, M.D., vice president of health and fitness at Apple.
The study is being conducted in partnership with OpenEvidence, a clinical AI platform used by healthcare professionals. OpenEvidence CEO Daniel Nadler posted on X that the collaboration combines two widely recognized brands.
"OpenEvidence is the most trusted and loved brand product among doctors. Apple is the most trusted and loved brand and product among consumers, and especially health consumers. So you have to bring these two things together. It’s like peanut butter and jelly."
Apple previously announced that a redesigned Health app, built around its Apple Intelligence AI, would be released to developers in the iOS 27.3 beta and rolled out to users as a free update by year-end. The November PYMNTS Intelligence Consumer AI Benchmark Report found that 39.7% of consumers using generative AI for health said the technology largely replaced their previous methods. OpenAI reported in January that more than 40 million people worldwide use ChatGPT daily for health queries, with health prompts accounting for over 5% of all messages.